Literature DB >> 12634400

Latency of viral expression in vivo is not related to CpG methylation in the U3 region and part of the R region of the long terminal repeat of bovine leukemia virus.

Shigeru Tajima1, Masako Tsukamoto, Yoko Aida.   

Abstract

Bovine leukemia virus (BLV) is silent in most cells detectable in vivo, and the repression of its expression allows BLV to evade the host's immune response. In this study, we examined whether CpG methylation of DNA might be involved in the regulation of the expression of BLV in vivo. To investigate the effects of CpG methylation on the activity of the long terminal repeat (LTR) of BLV, we measured the transactivation activity of this region after treatment with the CpG methyltransferase SssI by using a luciferase reporter system. The activity of methylated LTR was significantly lower than that of nonmethylated LTR. Therefore, we examined the extent of CpG methylation of the U3 region and part of the R region of the LTR in BLV-infected cattle and in experimentally BLV-infected sheep at various clinical stages by the bisulfite genomic sequencing method. We detected no or minimal CpG methylation at all stages examined in cattle and sheep, and our results indicate that CpG methylation probably does not participate in the silencing of BLV in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634400      PMCID: PMC150652          DOI: 10.1128/jvi.77.7.4423-4430.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Development of leukemia and lymphosarcoma induced by bovine leukemia virus in sheep: a hematopathological study.

Authors:  S Djilali; A L Parodi; D Levy; G L Cockerell
Journal:  Leukemia       Date:  1987-11       Impact factor: 11.528

2.  Methylation and expression of bovine leukemia proviral DNA.

Authors:  S V Kashmiri; R Mehdi; P Gupta; J F Ferrer
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

3.  Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short- and long-term cultures of infected cells.

Authors:  M F Clarke; C D Trainor; D L Mann; R C Gallo; M S Reitz
Journal:  Virology       Date:  1984-05       Impact factor: 3.616

4.  Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements.

Authors:  D Derse
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Effect of platelet-derived factor on expression of bovine leukemia virus genome.

Authors:  K Tsukiyama; M Onuma; H Izawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

Authors:  N Sagata; T Yasunaga; J Tsuzuku-Kawamura; K Ohishi; Y Ogawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Methylation pattern of human T-cell leukemia virus in vivo and in vitro: pX and LTR regions are hypomethylated in vivo.

Authors:  T Kitamura; M Takano; H Hoshino; K Shimotohno; M Shimoyama; M Miwa; F Takaku; T Sugimura
Journal:  Int J Cancer       Date:  1985-05-15       Impact factor: 7.396

8.  Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.

Authors:  R Kettmann; J Deschamps; Y Cleuter; D Couez; A Burny; G Marbaix
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  trans-acting regulation of bovine leukemia virus mRNA processing.

Authors:  D Derse
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  The bovine leukemia virus p34 is a transactivator protein.

Authors:  L Willems; A Gegonne; G Chen; A Burny; R Kettmann; J Ghysdael
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  12 in total

1.  DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcription factor binding.

Authors:  Valérie Pierard; Allan Guiguen; Laurence Colin; Gaëlle Wijmeersch; Caroline Vanhulle; Benoît Van Driessche; Ann Dekoninck; Jana Blazkova; Christelle Cardona; Makram Merimi; Valérie Vierendeel; Claire Calomme; Thi Liên-Anh Nguyên; Michèle Nuttinck; Jean-Claude Twizere; Richard Kettmann; Daniel Portetelle; Arsène Burny; Ivan Hirsch; Olivier Rohr; Carine Van Lint
Journal:  J Biol Chem       Date:  2010-04-22       Impact factor: 5.157

2.  Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.

Authors:  Makram Merimi; Pavel Klener; Maud Szynal; Yvette Cleuter; Pierre Kerkhofs; Arsène Burny; Philippe Martiat; Anne Van den Broeke
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

Review 3.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

Review 4.  Epidemiology and genetic diversity of bovine leukemia virus.

Authors:  Meripet Polat; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Virol J       Date:  2017-11-02       Impact factor: 4.099

5.  Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR.

Authors:  Carlos Javier Panei; Shin-nosuke Takeshima; Takashi Omori; Tetsuo Nunoya; William C Davis; Hiroshi Ishizaki; Kazuhiro Matoba; Yoko Aida
Journal:  BMC Vet Res       Date:  2013-05-04       Impact factor: 2.741

6.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

Review 7.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 8.  Chromatin, gene silencing and HIV latency.

Authors:  Hoi-Ping Mok; Andrew Ml Lever
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

9.  Early and transient reverse transcription during primary deltaretroviral infection of sheep.

Authors:  Carole Pomier; Maria T Sanchez Alcaraz; Christophe Debacq; Agnes Lançon; Pierre Kerkhofs; Lucas Willems; Eric Wattel; Franck Mortreux
Journal:  Retrovirology       Date:  2008-02-01       Impact factor: 4.602

Review 10.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.